Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

NCT06908993

Conditions
Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Besançon - CHU Besançon, France
  • Bordeaux - Institut Bergonie Bordeaux, France
  • Brest - CHU Brest, France
  • Caen - CRLCC Caen, France
View all 29 locations
View Trial Details
Recruiting

Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

NCT01639508

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

NCT05856981

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC, Colorectal Cancer, +47 more
Locations
  • Henry Ford Cancer Institute Detroit, Michigan, United States
  • Washington University Medical Campus St Louis, Missouri, United States
  • Gabrail Cancer & Research Center Canton, Ohio, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
View Trial Details
Recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

NCT06102057

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Universitätsklinik Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany
  • Universitätsklinikum Essen - Klinik für Strahlentherapie Essen, Germany
  • Medical Center - University Of Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Germany
  • Universitätsmedizin Göttingen, Department for Radiotherapy and Radiooncology Göttingen, Germany
View Trial Details
Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NCT06774963

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, +37 more
Locations
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
View all 14 locations
View Trial Details
Recruiting

A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery

NCT07182682

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Beijing Chest Hospital, Capital medical university Beijing, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship hospital Beijing, China
View all 49 locations
View Trial Details
Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations
  • University of Southern California Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT03556228

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
Locations
  • Providence Medical Foundation (site 209) Santa Rosa, California, United States
  • Hartford Hospital (site 210) Hartford, Connecticut, United States
  • The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
  • Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States
View all 15 locations
View Trial Details

Related conditions